Search research articles
Contact Us
Filters
Showing results (31-40 of 198) with videos related to
Page
of 20
Sort By:
General and Comparative Endocrinology
|
August 16, 2022
A basal actinopterygian melanocortin receptor: Molecular and functional characterization of an Mc2r ortholog from the Senegal bichir (Polypterus senegalus)
Ciaran A Shaughnessy, Mary F Jensen, Robert M Dores
Scientific Reports
|
October 26, 2021
Author Correction: Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment
Ciaran A Shaughnessy, Pamela L Zeitlin, Preston E Bratcher
Allergy and Asthma Proceedings
|
February 24, 2001
Clinical and immunologic outcome of 42 individuals with trimellitic anhydride-induced immunologic lung disease after transfer to low exposure
L C Grammer, M A Shaughnessy, B D Kenamore
Allergy Proceedings : the Official Journal of Regional and State Allergy Societies
|
September 1, 1990
Absence of nasal priming as measured by rhinitis symptom scores of ragweed allergic patients during seasonal exposure to ragweed pollen
L Grammer, C Wiggins, M A Shaughnessy, et al.
Fish Physiology and Biochemistry
|
March 26, 2022
The isosmotic point as critical salinity limit for growth and osmoregulation, but not survival, in the wolf eel Anarrhichthys ocellatus
Ciaran A Shaughnessy, Shannon K Balfry, Jason S Bystriansky
Journal of Virology
|
March 1, 1989
Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide
R G Paterson, M A Shaughnessy, R A Lamb
Journal of Immunological Methods
|
March 11, 1983
A solid-phase bead radioimmunoassay for specific IgE to ragweed antigen E
L C Grammer, M A Shaughnessy, J J Pruzansky
The Journal of Laboratory and Clinical Medicine
|
May 1, 1996
Risk factors for immunologically mediated disease in workers with respiratory symptoms when exposed to hexahydrophthalic anhydride
L C Grammer, M A Shaughnessy, P R Yarnold
Scientific Reports
|
October 7, 2021
Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment
Ciaran A Shaughnessy, Pamela L Zeitlin, Preston E Bratcher
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
March 6, 2022
Net benefit of ivacaftor during prolonged tezacaftor/elexacaftor exposure in vitro
Ciaran A Shaughnessy, Pamela L Zeitlin, Preston E Bratcher
Page
of 20
Search research articles
Search
Showing results (31-40 of 198) with videos related to
Sort By:
Page
of 20
General and Comparative Endocrinology
|
August 16, 2022
A basal actinopterygian melanocortin receptor: Molecular and functional characterization of an Mc2r ortholog from the Senegal bichir (Polypterus senegalus)
Ciaran A Shaughnessy, Mary F Jensen, Robert M Dores
Scientific Reports
|
October 26, 2021
Author Correction: Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment
Ciaran A Shaughnessy, Pamela L Zeitlin, Preston E Bratcher
Allergy and Asthma Proceedings
|
February 24, 2001
Clinical and immunologic outcome of 42 individuals with trimellitic anhydride-induced immunologic lung disease after transfer to low exposure
L C Grammer, M A Shaughnessy, B D Kenamore
Allergy Proceedings : the Official Journal of Regional and State Allergy Societies
|
September 1, 1990
Absence of nasal priming as measured by rhinitis symptom scores of ragweed allergic patients during seasonal exposure to ragweed pollen
L Grammer, C Wiggins, M A Shaughnessy, et al.
Fish Physiology and Biochemistry
|
March 26, 2022
The isosmotic point as critical salinity limit for growth and osmoregulation, but not survival, in the wolf eel Anarrhichthys ocellatus
Ciaran A Shaughnessy, Shannon K Balfry, Jason S Bystriansky
Journal of Virology
|
March 1, 1989
Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide
R G Paterson, M A Shaughnessy, R A Lamb
Journal of Immunological Methods
|
March 11, 1983
A solid-phase bead radioimmunoassay for specific IgE to ragweed antigen E
L C Grammer, M A Shaughnessy, J J Pruzansky
The Journal of Laboratory and Clinical Medicine
|
May 1, 1996
Risk factors for immunologically mediated disease in workers with respiratory symptoms when exposed to hexahydrophthalic anhydride
L C Grammer, M A Shaughnessy, P R Yarnold
Scientific Reports
|
October 7, 2021
Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment
Ciaran A Shaughnessy, Pamela L Zeitlin, Preston E Bratcher
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
March 6, 2022
Net benefit of ivacaftor during prolonged tezacaftor/elexacaftor exposure in vitro
Ciaran A Shaughnessy, Pamela L Zeitlin, Preston E Bratcher
Page
of 20